- SEK457.99m
- SEK288.67m
- SEK180.16m
Brief: Ossdsign Q3 Loss After Taxes Amounted To Tsek 16,531
Brief: Karolinska Development's Portfolio Company Ossdsign Receives Expanded FDA Market Clearance For Ossdsign Cranial PSI
Brief: OssDsign Receives Expanded FDA Market Clearance For OssDsign Cranial PSI
Brief: Ossdsign Enters Into Cooperation Agreement With Red One Medical
Brief: Ossdsign Signs Agreement With Premier Inc
Brief: OssDsign: Orthobiological Product OssDsing Catalyst Evaluated In Preclinical Study
Brief: Ossdsign Raises SEK 270 Mln In Oversubscribed Rights Issue And Utilised Over-Allotment Option
Brief: OssDsign: Scientific Paper Confirms Osteointegration Of Co's Cranial PSI Implants
Brief: OssDsign Q1 Loss After Taxes Widens To SEK 23.3 Mln
Brief: Anders Svensson Joins OssDsign As CFO
Brief: Ossdsign Updates Its Strategy And Establishes New Financial Ambitions
Brief: OssDsign Q4 Loss After Taxes Narrows To SEK 25.0 Mln
Brief: OssDsign Presents New Clinical Data With OssDsign Cranial PSI
Brief: OssDsign CFO Resigns
Brief: OssDsign Q3 Loss After Taxes Narrows To SEK 18.7 Mln
Brief: OssDsign Q3 Net Loss Narrows To SEK 18.7 Mln
Brief: OssDsign Acquires Sirakoss
Brief: Ossdsign Says Carried Out Directed Share Issue Raising Proceeds Of About SEK 65 Mln To Finance The Sirakoss Acquisition
Brief: OssDsign: Bone Regenerative Potential Of Co's Technology Confirmed In Scientific Journal PNAS